Navigation Links
China Medicine to Present at CCG IR's China Rising Conference in New York

GUANGZHOU, China, May 5 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and dietary-supplements, medical devices, and medical formulations in the People's Republic of China ("PRC"), announced today that the Company's management will present at the upcoming China Rising Conference hosted by CCG Investor Relations in New York, NY on May 18, 2009.

The date, time and location of China Medicine's presentation at the China Rising Conference are as follows:

    Date:           Monday, May 18, 2009
    Time:           1:30 p.m. to 2:00 p.m. Eastern Time
    Presenter:      Mr. Senshan Yang, Chief Executive Officer
                    Ms. Minhua Liu, Executive Vice President
                    Ms. Gavin Chen, CFO Assistant
    Venue:          The Yale Club
                    50 Vanderbilt Avenue
                    New York, NY 10017

A replay of the webcast will be available for up to one year following the presentation using the same link.

The China Rising Investment Conference hosted by CCG Investor Relations will provide over 250 fund managers and investors access to senior management of a wide range of Chinese growth companies in sectors including consumer staples, agriculture, pharmaceuticals, infrastructure, information technology, advanced materials, capital goods, and alternative energy. The conference will include over 30 US-listed Chinese companies and a number of private companies.

Interested parties and investors may find more information for the conference by visiting the website at

About China Medicine Corporation

China Medicine Corporation is a developer and leading distributor of prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine also has its research and development force for certain products it manufactures through OEM arrangement makes the distribution. The Company distributes its products to wholesale distributors including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. The Company actively develops a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risks factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

    Company Contact:                 Investor Relations Contact:
    Ms. Huizhen Yu                   Mr. Crocker Coulson, President
    Chief Financial Officer          CCG Investor Relations
    China Medicine Corp              Tel: +1-646-213-1915 (NY Office)
    Tel: +86-20-8739-1718            E-mail:
    E-mail:        Website:

SOURCE China Medicine Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IBM Announces New Healthcare Industry Solutions Lab in China
2. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
3. China Pharma Holdings, Inc. Retains Global Investor Communications Team
4. goBalto Partners With ChinaBio to Expand Its List of Contract Research Organizations
5. China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member
6. Milestone Scientific Grants Sinopharm Exclusive Distribution and Marketing Rights to STA System in China
7. NIAID and Chinese officials sign agreement to foster TB research in Chinas Henan province
8. China Seeks to Transform Healthcare Sector with Information Technology
9. China Medicine Corporation Achieves Major Milestone for rADTZ
10. Majority of doctors skeptical of organ transplantation practices in China
11. A Message to Investors from China Sky One Medical, Inc.
Post Your Comments:
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions announced ... User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of Dynamics ... software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to ... Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored ... one of twelve colleges and universities in the state of California make the cut. ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., ... the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 ... brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... -- Research and Markets ( ) has announced the ... to 2019 - Rise in Cardiac Disorders and Growing Awareness ... their offering. Boston scientific ... scientific and others. --> The market is ... Boston scientific and others. ...
(Date:11/26/2015)... 26, 2015 ... "2016 Future Horizons and Growth Strategies ... Market: Supplier Shares, Country Segment Forecasts, Competitive ... offering. --> ) has ... Future Horizons and Growth Strategies in the ...
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
Breaking Medicine Technology: